BIIB

Biogen

Halal Rating :
Comfortable
Last Price $146.50 Last updated:
Market Cap $29.83b
7D Change -2.35%
1 Year Change -42.29%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Biological Products
  • Except Diagnostic Substances
Exchange NASDAQ
Next Earnings Date Nov. 6, 2024

Biogen Inc. is a global biotechnology company focused on discovering, developing, and delivering innovative therapies for people living with serious neurological diseases. The company specializes in treatments for multiple sclerosis (MS), spinal muscular atrophy (SMA), Alzheimer's disease, and biosimilars. Their product portfolio includes several important medications such as TECFIDERA, TYSABRI, and SPINRAZA.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $2.47b $2.01b - - 0.00% 0.00%
June 30, 2024 $2.46b $1.77b - - 0.00% 0.00%
March 31, 2024 $2.29b $1.83b - - 0.00% 0.00%

Company Impact

Help us evaluate Biogen's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates